2005
DOI: 10.1007/s11748-005-1001-y
|View full text |Cite
|
Sign up to set email alerts
|

Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis

Abstract: The present study demonstrated that preoperative plasmapheresis may facilitate improved outcomes of patients with myasthenia gravis after thymectomy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
1
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(28 citation statements)
references
References 26 publications
2
24
1
1
Order By: Relevance
“…In patients with myasthenia gravis, which included 16 patients, the improvement rate was 81.25%. This was in agreement with studies done by Nagayasu et al [14], who stated remission rate at (79%), and Sarkar et al [15] who stated remission rate of 80%. The difference at improvement rate could be attributed to the total number of cases studied.…”
Section: Discussionsupporting
confidence: 93%
“…In patients with myasthenia gravis, which included 16 patients, the improvement rate was 81.25%. This was in agreement with studies done by Nagayasu et al [14], who stated remission rate at (79%), and Sarkar et al [15] who stated remission rate of 80%. The difference at improvement rate could be attributed to the total number of cases studied.…”
Section: Discussionsupporting
confidence: 93%
“…Yeh et al [8] and Nagayasu et al [9] suggested that preoperative plasmapheresis may facilitate improved outcomes of patients with myasthenia gravis after thymectomy; however our study showed that the post-operative outcome was not different between the two groups. There was no difference in immediate post-operative extubation time, length of hospital stay, and 30-day mortality.…”
Section: Discussioncontrasting
confidence: 86%
“…Disease‐modifying therapies for MG include immunosuppression with oral prednisone (PSL), azathioprine, cyclosporine, or tacrolimus . More aggressive exacerbation of MG often requires additional immunomodulatory treatment with plasma exchange/plasmapheresis (PE/PP) and/or intravenous immunoglobulin (IVIg) …”
mentioning
confidence: 99%